بدائل البحث:
significant declines » significant decline (توسيع البحث), significantly declined (توسيع البحث), significant nonlinear (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
significant genes » significant gender (توسيع البحث), significant benefits (توسيع البحث), significant changes (توسيع البحث)
significant declines » significant decline (توسيع البحث), significantly declined (توسيع البحث), significant nonlinear (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
significant genes » significant gender (توسيع البحث), significant benefits (توسيع البحث), significant changes (توسيع البحث)
-
1841
-
1842
-
1843
-
1844
-
1845
<b>Nest mass in forest tits </b><b><i>Paridae</i></b><b> </b><b>increases with elevation and decreasing body mass, promoting reproductive success</b>
منشور في 2025"…We found that nest mass increased by ~ 60% along the elevational gradient, but the effect of canopy openness on nest mass was not significant, while nest mass decreased along the ranked species from the smallest <i>Periparus ater</i> to the medium-sized <i>Cyanistes caeruleus</i> and the largest <i>Parus major</i>. …"
-
1846
-
1847
-
1848
-
1849
-
1850
-
1851
Cis-acting elements in the promoter of PtWRKYs.
منشور في 2025"…Based on RNA-Seq, we identified 83 <i>WRKYs</i> significantly respond to cadmium (Cd) stress. Subsequently, we conducted a study on <i>WRKY95</i>, which was significantly up-regulated in the roots, stems, and leaves under Cd stress. …"
-
1852
The primer sequences for RT-qPCR.
منشور في 2025"…Based on RNA-Seq, we identified 83 <i>WRKYs</i> significantly respond to cadmium (Cd) stress. Subsequently, we conducted a study on <i>WRKY95</i>, which was significantly up-regulated in the roots, stems, and leaves under Cd stress. …"
-
1853
Summary of post-treatment disease course measures from MDMA-AT publications.
منشور في 2025الموضوعات: -
1854
-
1855
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
منشور في 2025الموضوعات: -
1856
-
1857
-
1858
-
1859
Summary of post-treatment disease course measures from off-label medications clinical trials.
منشور في 2025الموضوعات: -
1860
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
منشور في 2025الموضوعات: